Insulin resistance is the basis of both non‐alcoholic fatty liver disease (NAFLD) and
metabolic syndrome (MetS), the two conditions are often found in the same individual. The …

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is getting an
increasing attention for its clinical implications on cardiovascular disease (CVD). However …

Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common
conditions that regularly co-exist and can act synergistically to drive adverse outcomes. The …

Objective Follow-up studies have shown that non-alcoholic fatty liver disease (NAFLD) is
associated with an increased risk of incident diabetes, but currently, it is uncertain whether …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the developed world, with a global prevalence of around 25%. NAFLD is considered to be …

Abstract Background and Aim: The magnitude of the risk of incident type 2 diabetes (T2D)
and metabolic syndrome (MetS) among patients with nonalcoholic fatty liver disease …

Nonalcoholic fatty liver disease (NAFLD) is known as a risk of incident cardiovascular
disease (CVD). About 20% of NAFLD occurs in nonobese individuals. However, it remains …

Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) frequently
coexist as they share the pathogenic abnormalities of excess adiposity and insulin …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, and is
strongly associated with the metabolic syndrome. In the last decade, it has become apparent …